Speakers
Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.
If you have a cutting edge case study or relevant presentation and would like to join the speaker panel at one of our events, please contact Charlotte Tighe at c.tighe@oxfordglobal.co.uk
Confirmed speakers
- Les Baillie
Professor of Microbiology, Welsh School of Pharmacy, Cardiff University - Susan Barnett
Senior Director, Novartis Vaccines and Diagnostics - Cécile Bauche
R&D Director, Theravectys - Tamar Ben-Yedidia
CSO, Biondvax
- Thomas Blanchard
Honorary Senior Lecturer, Consultant in Infectious Diseases, Department of Virology, Manchester University - Miles Carroll,
Deputy Director, Head of Research, Health Protection Agency - Danilo Casimiro
Director, Vaccine Research, Merck - Simona Cianetti
Formulation Manager, Novartis Vaccines and Diagnostics - James Cummings
Director, Translational Medicine Branch, WRAIR, assistant Professor of Medicine, Uniformed University of Health Sciences - Ennio De Gregorio,
Head, Research Italy, Head, Immunology Italy, Novartis Vaccines and Diagnostics Srl - Parimal Desai,
Head of Manufacturing Sciences and Commercialization, Merck Vaccine - Barbara Domayne-Hayman,
CEO, Stabilitech - Michael G. Hanna
Chairman, CSO, Vaccinogen - Arin Ghasparian
Co-founder and CSO, Virometix - André Habel,
Chief Technology Officer, Themis BioScience - Rod Hafner
SVP Research and Development, Circassia - Bassam Hallis,
General Project Manager, Health Protection Agency - Kathrin U. Jansen,
Senior Vice President, Vaccine Research East & Early Development, Pfizer - Joseph Joyce
Director, Vaccines Basic Research, Merck Research Laboratories - Christiane Juhls
Head of DNA Vaccine Department, Mologen - Beate Kampmann
Professor in Paediatric Infection & Immunity, NIHR Senior Research Fellow - Stefan Kostense,
Director Clinical Assays, Crucell - Michael Kowarik
Glycovaxyn - Alex Kudrin,
Takeda Global Research & Development Centre (Europe) Ltd., UK, Medical Director, Gastroenterology, Immunology/Inflammation and Vaccines - Kaare Lund,
Director of Global Innovation Management, ALK Abelló - Mike McCarthy
Director, Infectious Disease/Vaccines Research, MedImmune - David McIntosh,
Global Scientific Affairs Senior Expert, Novartis - James Merson
SVP, Head Vaccine Research, Pfizer Inc - Lyn Morgan
Director Regulatory Affairs, Development Products, Sanofi Pasteur - Tarit Mukhopadhyay,
Lecturer in Vaccine Bioprocess Development, University College London - Alistair Noble
Senior Lecturer, Kings College London - Michele Pallaoro
Unit Head, Formulation & Delivery Department, Novartis Vaccines and Diagnostics - Athanasios Papadopoulos
Global Clinical Research Physician, Senior Medical Advisor Lead, Novartis Vaccines and Diagnostics - Sonia Quaratino,
Professor and Senior Medical Director and Immunology Advisor, Merck Serono, Global Clinical Development Unit, Oncology - Robert Rees
Professor, School of Science and Technology, Nottingham Trent University - Philip Roopram
Sr. CPM Director, CPM Infectious Diseases/Vaccines, Quintiles - Elisa Scarselli
Clinical Director, Okairos - Robin Shattock
Professor of Mucosal Infection and Immunity, Imperial College London - De-chu Tang
Founder, VP and CTO, Vaxin - Malcolm Thomas
CEO, Arbovax - Tao Yuan
Senior Scientist, Bioprocess R&D, Sanofi Pasteur, Canada
